20,051 Shares in CVS Health Corporation $CVS Acquired by Haverford Trust Co

Haverford Trust Co bought a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The fund bought 20,051 shares of the pharmacy operator’s stock, valued at approximately $2,074,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the period. Swiss RE Ltd. bought a new stake in shares of CVS Health in the fourth quarter worth $26,000. Kilter Group LLC acquired a new stake in CVS Health in the second quarter valued at $27,000. Sankala Group LLC bought a new position in CVS Health during the 4th quarter worth $28,000. Finally, Global Trust Asset Management LLC lifted its holdings in CVS Health by 344.8% during the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 300 shares during the period. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on CVS shares. Royal Bank Of Canada upped their price target on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Truist Financial lifted their price objective on CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. UBS Group upped their target price on CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Morgan Stanley increased their target price on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Finally, Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Performance

Shares of CVS Health stock opened at $93.01 on Friday. The business has a 50-day moving average price of $102.02 and a two-hundred day moving average price of $88.86. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The company has a market cap of $118.96 billion, a P/E ratio of 24.61, a PEG ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the previous year, the business earned $1.81 EPS. The firm’s revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is presently 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.